Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Couch

Showing results (411-420 of 697) with videos related to

Pageof 70
Sort By:
Cell Reports|December 3, 2014
The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressorKristen L Karlin, Gourish Mondal, Jessica K Hartman, et al.
JCO Precision Oncology|September 21, 2020
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary CancersKara N Maxwell, Brandon M Wenz, Abha Kulkarni, et al.
Breast Cancer Research and Treatment|April 17, 2016
Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypesKristen S Purrington, Daniel W Visscher, Chen Wang, et al.
NPJ Breast Cancer|February 18, 2022
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancerKirsten G M Aspros, Jodi M Carter, Tanya L Hoskin, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
Cancer Research|January 24, 2012
Mammographic breast density and breast cancer: evidence of a shared genetic basisJajini S Varghese, Deborah J Thompson, Kyriaki Michailidou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.
Journal of the National Cancer Institute|October 16, 2024
Polygenic risk scores stratify breast cancer risk among women with benign breast diseaseMark E Sherman, Stacey J Winham, Robert A Vierkant, et al.
Journal of Medical Genetics|February 4, 2015
BRCA1 Circos: a visualisation resource for functional analysis of missense variantsAnkita Jhuraney, Aneliya Velkova, Randall C Johnson, et al.
Journal of the National Cancer Institute|May 20, 2020
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American WomenJulie R Palmer, Eric C Polley, Chunling Hu, et al.
Pageof 70

Showing results (411-420 of 697) with videos related to

Sort By:
Pageof 70
Cell Reports|December 3, 2014
The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressorKristen L Karlin, Gourish Mondal, Jessica K Hartman, et al.
JCO Precision Oncology|September 21, 2020
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary CancersKara N Maxwell, Brandon M Wenz, Abha Kulkarni, et al.
Breast Cancer Research and Treatment|April 17, 2016
Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypesKristen S Purrington, Daniel W Visscher, Chen Wang, et al.
NPJ Breast Cancer|February 18, 2022
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancerKirsten G M Aspros, Jodi M Carter, Tanya L Hoskin, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
Cancer Research|January 24, 2012
Mammographic breast density and breast cancer: evidence of a shared genetic basisJajini S Varghese, Deborah J Thompson, Kyriaki Michailidou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.
Journal of the National Cancer Institute|October 16, 2024
Polygenic risk scores stratify breast cancer risk among women with benign breast diseaseMark E Sherman, Stacey J Winham, Robert A Vierkant, et al.
Journal of Medical Genetics|February 4, 2015
BRCA1 Circos: a visualisation resource for functional analysis of missense variantsAnkita Jhuraney, Aneliya Velkova, Randall C Johnson, et al.
Journal of the National Cancer Institute|May 20, 2020
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American WomenJulie R Palmer, Eric C Polley, Chunling Hu, et al.
Pageof 70